BioAdaptives Statistics

Total Valuation

BioAdaptives has a market cap or net worth of 109,279. The enterprise value is 335,388.

Market Cap	109,279
Enterprise Value	335,388

Important Dates

The next estimated earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

BioAdaptives has 12.01 million shares outstanding. The number of shares has increased by 22.61% in one year.

Current Share Class	12.01M
Shares Outstanding	12.01M
Shares Change (YoY)	+22.61%
Shares Change (QoQ)	+17.49%
Owned by Insiders (%)	2.08%
Owned by Institutions (%)	n/a
Float	11.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.98
PB Ratio	-0.05
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.22
EV / Sales	18.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.63

Financial Position

The company has a current ratio of 0.09

Current Ratio	0.09
Quick Ratio	0.07
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.72
Interest Coverage	-14.70

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-267.07%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	48.93%
Weighted Average Cost of Capital (WACC)	13.91%
Revenue Per Employee	18,278
Profits Per Employee	-1.56M
Employee Count	1
Asset Turnover	0.07
Inventory Turnover	0.18

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.50% in the last 52 weeks. The beta is 1.34, so BioAdaptives's price volatility has been higher than the market average.

Beta (5Y)	1.34
52-Week Price Change	-87.50%
50-Day Moving Average	0.02
200-Day Moving Average	0.04
Relative Strength Index (RSI)	41.00
Average Volume (20 Days)	44,538

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.12

Income Statement

In the last 12 months, BioAdaptives had revenue of 18,278 and -1.56 million in losses. Loss per share was -0.15.

Revenue	18,278
Gross Profit	12,497
Operating Income	-1.04M
Pretax Income	-1.56M
Net Income	-1.56M
EBITDA	-1.04M
EBIT	-1.04M
Loss Per Share	-0.15

Full Income Statement

Balance Sheet

The company has 158,445 in cash and 384,428 in debt, giving a net cash position of -225,983 or -0.02 per share.

Cash & Cash Equivalents	158,445
Total Debt	384,428
Net Cash	-225,983
Net Cash Per Share	-0.02
Equity (Book Value)	-2.13M
Book Value Per Share	-0.18
Working Capital	-2.14M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -516,025 and capital expenditures -18,000, giving a free cash flow of -534,025.

Operating Cash Flow	-516,025
Capital Expenditures	-18,000
Depreciation & Amortization	4,000
Net Borrowing	255,000
Free Cash Flow	-534,025
FCF Per Share	-0.04

Full Cash Flow Statement

Margins

Gross Margin	68.37%
Operating Margin	-5,701.79%
Pretax Margin	-8,523.35%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioAdaptives does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.61%
Shareholder Yield	-22.61%
Earnings Yield	-1,425.62%
FCF Yield	-488.68%

Stock Splits

The last stock split was on January 23, 2025. It was a forward split with a ratio of 2.

Last Split Date	Jan 23, 2025
Split Type	Forward
Split Ratio	2

Scores

BioAdaptives has an Altman Z-Score of -92.84 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-92.84
Piotroski F-Score	3